In a field as complex as toxicogenomics, which requires skills in so many disciplines, forming relationships with researchers and technology companies is crucial. Iconix is committed to building development alliances with companies that possess the highest levels of expertise in areas that are critical to toxicogenomics, such as pharmacology, chemoinformatics, and genomics. Iconix is equally committed to building collaborative research relationships to grow the Company’s products and skill set in ways that best meets the needs of the pharmaceutical and biotechnology industries.